Clinical Trials On Candidate Drug For TB Under OSDD To Begin Soon

Putting the search for the first indigenous drug for tuberculosis on an advanced stage, the clinical trial of the candidate drug under the unique model of open source drug discovery (OSDD) programme will start soon.

“The committees have been formed and site has been identified for the clinical trial of the drug. We are waiting for the clearance from the Drug Controller General of India (DCGI) for carrying out the trials,” CSIR director general and the Secretary to the Department of Scientific and Industrial Research Dr Samir K Brahmachair told Pharmbiz.

The trials would take place at the LSR Hospital for Respiratory and Infectious Disease, New Delhi. The phase will involve around 250-300 patients. “We will begin the trials as soon as the approval comes. All other things are in place,” he added.